Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Voriconazole serum concentrations in obese and overweight immunocompromised patients: a retrospective review.

Davies-Vorbrodt S, Ito JI, Tegtmeier BR, Dadwal SS, Kriengkauykiat J.

Pharmacotherapy. 2013 Jan;33(1):22-30. doi: 10.1002/phar.1156. Review.

PMID:
23307541
2.

Epidemiology and treatment approaches in management of invasive fungal infections.

Kriengkauykiat J, Ito JI, Dadwal SS.

Clin Epidemiol. 2011;3:175-91. doi: 10.2147/CLEP.S12502. Epub 2011 May 19.

3.

Nontyphoidal Salmonella infection among recipients of hematopoietic SCT.

Dadwal SS, Tegtmeier B, Nakamura R, Kriengkauykiat J, Ito J, Forman SJ, Pullarkat V.

Bone Marrow Transplant. 2011 Jun;46(6):880-3. doi: 10.1038/bmt.2010.204. Epub 2010 Sep 13.

PMID:
20838389
4.

Approaches to the early treatment of invasive fungal infection.

Ito JI, Kriengkauykiat J, Dadwal SS, Arfons LM, Lazarus HM.

Leuk Lymphoma. 2010 Sep;51(9):1623-31. doi: 10.3109/10428194.2010.496504. Review.

PMID:
20629521
5.

Lack of effect of P-glycoprotein inhibition on renal clearance of dicloxacillin in patients with cystic fibrosis.

Beringer PM, Kriengkauykiat J, Zhang X, Hidayat L, Liu S, Louie S, Synold T, Burckart GJ, Rao PA, Shapiro B, Gill M.

Pharmacotherapy. 2008 Jul;28(7):883-94. doi: 10.1592/phco.28.7.883.

PMID:
18576903
6.

Absolute bioavailability and intracellular pharmacokinetics of azithromycin in patients with cystic fibrosis.

Beringer P, Huynh KM, Kriengkauykiat J, Bi L, Hoem N, Louie S, Han E, Nguyen T, Hsu D, Rao PA, Shapiro B, Gill M.

Antimicrob Agents Chemother. 2005 Dec;49(12):5013-7.

7.
8.

Systemic antifungal therapy: new options, new challenges.

Wong-Beringer A, Kriengkauykiat J.

Pharmacotherapy. 2003 Nov;23(11):1441-62. Review.

PMID:
14620391

Supplemental Content

Loading ...
Support Center